Definition

Actinic Keratosis is a premalignant intraepidermal keratinocytic proliferation caused by cumulative ultraviolet (UV) radiation damage, occurring predominantly on chronically sun-exposed skin.

It represents:

• Early in-situ squamous dysplasia

• A precursor lesion to cutaneous squamous cell carcinoma (cSCC)

The term “field cancerization” is important because clinically visible lesions are usually accompanied by widespread subclinical UV-induced genetic damage.

EPIDEMIOLOGY

• Very common in fair-skinned individuals

• Increased with:

  • Age

  • Chronic sun exposure

  • Immunosuppression

  • Outdoor occupations

  • Male sex

• Common in:

  • Bald scalp

  • Face

  • Ears

  • Dorsal hands

  • Forearms

ETIOLOGY & RISK FACTORS

Ultraviolet Radiation

Main etiologic factor:

• Chronic UVB exposure

UVA contributes through:

• Oxidative DNA injury

• Photoaging

Important Risk Factors

• Fitzpatrick I–II skin

• Chronic sun exposure

• Immunosuppression (especially transplant recipients)

• Older age

• Xeroderma pigmentosum

• Previous skin cancers

• Arsenic exposure

FOUNDATIONS (First Principles)

Normal Epidermal Histology

The epidermis contains:

• Basal keratinocytes (proliferative layer)

• Spinous layer keratinocytes

• Granular layer

• Cornified layer

Normal keratinocyte maturation:

• Begins in basal layer

• Progresses upward in orderly differentiation

• Ends with anucleate stratum corneum formation

DNA repair systems normally correct UV-induced injury.

Function of Keratinocytes

Keratinocytes:

• Form epidermal barrier

• Protect against UV injury

• Produce cytokines

• Undergo regulated differentiation and apoptosis

The p53 tumor suppressor pathway normally removes UV-damaged cells.

INITIATING EVENT

Earliest Abnormality

UV-induced DNA damage in epidermal keratinocytes.

Most important mutation:

• TP53 mutation

UV radiation causes:

• Pyrimidine dimers

• Oxidative DNA damage

If repair fails:

• Mutated keratinocyte clones survive and expand.

PATHOGENESIS

Step 1: Chronic UV Exposure

Repeated UV exposure causes cumulative DNA injury.

Step 2: Mutation Accumulation

Mutations occur in:

• TP53

• NOTCH genes

• CDKN2A

• Other tumor suppressors

p53 dysfunction prevents apoptosis of damaged cells.

Step 3: Clonal Expansion

Atypical keratinocytes proliferate within epidermis.

Normal maturation becomes disordered.

Step 4: Epidermal Dysplasia

Atypical keratinocytes extend upward variably.

Result:

• Disordered stratification

• Hyperkeratosis

• Parakeratosis

Step 5: Progression Potential

Some lesions progress to:

• Squamous cell carcinoma in situ

• Invasive squamous cell carcinoma

Risk increases with:

• Immunosuppression

• Extensive lesions

• Persistent inflammation

CLINICAL FEATURES

Morphology

• Rough, scaly papule or plaque

• Better felt than seen initially

• Adherent scale

Color:

• Erythematous

• Skin-colored

• Brownish

Common Sites

Chronically sun-exposed areas:

• Face

• Scalp

• Helix of ear

• Dorsal hands

• Forearms

• Lower lip (actinic cheilitis)

Clinical Variants

Hypertrophic Actinic Keratosis

Marked hyperkeratosis.

Atrophic Actinic Keratosis

Thin erythematous lesion with minimal scale.

Pigmented Actinic Keratosis

May mimic lentigo maligna.

Bowenoid Actinic Keratosis

More pronounced atypia resembling SCC in situ.

Actinic Cheilitis

Involvement of lower lip vermilion.

Premalignant for SCC.

HISTOPATHOLOGY EXPLAINED

1. FOUNDATIONS

Normal Epidermis

Normal epidermis demonstrates:

• Basal proliferation

• Ordered maturation upward

• Basket-weave orthokeratosis

Keratinocytes mature progressively as they migrate to surface.

2. INITIATING EVENT

UV-induced DNA injury causes:

• Mutated basal keratinocytes

• Failure of apoptosis

• Clonal atypical proliferation

The earliest atypia usually begins in basal keratinocytes.

3. PATHOGENESIS

Mutated keratinocytes:

• Proliferate abnormally

• Lose polarity

• Show disturbed differentiation

Abnormal maturation produces:

• Parakeratosis

• Hyperkeratosis

• Epidermal atypia

Solar elastosis develops in dermis due to chronic UV damage.

4. HISTOPATHOLOGY EXPLAINED

Key Histologic Features

Partial-Thickness Keratinocyte Atypia

Atypical keratinocytes predominantly involve lower epidermis.

Features:

• Enlarged hyperchromatic nuclei

• Pleomorphism

• Loss of polarity

Why?
DNA mutations disrupt normal maturation control.

Parakeratosis

Retention of nuclei within stratum corneum.

Normally:

• Cornified cells lose nuclei.

In AK:

• Accelerated abnormal maturation prevents complete keratinization.

Parakeratosis often alternates with orthokeratosis.

“Flag Sign”

Alternating:

• Parakeratosis over atypical epidermis

• Orthokeratosis over adnexal ostia

Board-favorite feature.

Why?
Adnexal epithelium may mature relatively normally.

Hyperkeratosis

Thickened stratum corneum.

Produced by:

• Increased keratinocyte proliferation

• Abnormal differentiation

Acanthosis

Epidermal thickening.

May be:

• Mild

• Marked in hypertrophic AK

Solar Elastosis

Basophilic degenerative elastic fibers in dermis.

Caused by:

• Chronic UV-induced dermal matrix degeneration.

Represents chronic photodamage.

Lymphocytic Infiltrate

Mild superficial inflammatory infiltrate may occur.

Reflects:

• Immune response against dysplastic keratinocytes.

5. TEMPORAL EVOLUTION

Early Lesions

• Subtle basal atypia

• Minimal scale

Established Lesions

• More obvious dysplasia

• Hyperkeratosis

• Parakeratosis

• Solar elastosis

Advanced/Bowenoid Lesions

• Full-thickness atypia

• Closer to SCC in situ

Progression to SCC

Features suggesting invasion:

• Dermal infiltration

• Irregular nests

• Stromal desmoplasia

6. NAMING LOGIC & TERMINOLOGY

“Actinic”

Means induced by radiant energy (sunlight).

“Keratosis”

Refers to abnormal keratinization.

“Solar Elastosis”

“Solar” = sun-induced.
“Elastosis” = abnormal elastic tissue degeneration.

“Parakeratosis”

“Para” = beside/abnormal.
“Karyosis” refers to retained nuclei.

Thus:

• Keratin layer retaining nuclei.

7. STAINING & MARKERS

H&E

Shows:

• Keratinocyte atypia

• Hyperchromasia

• Solar elastosis

• Parakeratosis

p53 Immunostaining

May show increased staining due to mutated p53 accumulation.

Not routinely necessary clinically.

Ki-67

Highlights increased proliferative activity.

8. PATTERN RECOGNITION & DIAGNOSTIC LOGIC

Histologic Clues Favoring AK

• Partial-thickness atypia

• Solar elastosis

• Parakeratosis

• UV-damaged skin

Differentiate From SCC in situ (Bowen Disease)

AK

• Usually partial-thickness atypia

Bowen Disease

Bowen Disease:

• Full-thickness atypia

• More diffuse dysplasia

Differentiate From Invasive SCC

In SCC:

• Tumor cells invade dermis

• Keratin pearls may form

• Stromal reaction present

Differentiate From Seborrheic Keratosis

Seborrheic Keratosis:

• No keratinocyte atypia

• Horn cysts common

9. CLINICO-PATHOLOGICAL CORRELATION

Why Lesions Feel Rough

Hyperkeratosis and abnormal stratum corneum create rough texture.

Why Lesions Occur on Sun-Exposed Skin

UV damage is cumulative and localized to exposed sites.

Why Elderly Patients Are Commonly Affected

Mutational burden accumulates over decades.

Why Immunosuppressed Patients Develop Extensive Disease

Immune surveillance against dysplastic keratinocytes is impaired.

FIELD CANCERIZATION

Important board concept.

Refers to:

• Large areas of UV-damaged skin containing genetically altered keratinocytes.

Explains:

• Multiple lesions

• Recurrence

• New lesion development

DIFFERENTIAL DIAGNOSIS

• Bowen disease

• Early SCC

• Seborrheic keratosis

• Discoid lupus erythematosus

• Superficial basal cell carcinoma

• Porokeratosis

• Chronic eczema

MANAGEMENT

LESION-DIRECTED THERAPY

Cryotherapy

Most common treatment.

Mechanism:

• Cellular ice crystal formation → necrosis

Good for:

• Few discrete lesions

Curettage ± Electrodessication

Useful for:

• Hypertrophic lesions

Excision

If invasive SCC suspected.

FIELD THERAPY

Treats visible and subclinical lesions.

5-Fluorouracil

Fluorouracil

Mechanism:

• Inhibits thymidylate synthase

• Preferentially destroys dysplastic keratinocytes

Produces intense inflammatory reaction.

Imiquimod

Imiquimod

Activates:

• Toll-like receptor 7

Enhances:

• Antitumor immune response

Diclofenac Gel

Diclofenac

Less effective but well tolerated.

Photodynamic Therapy (PDT)

Uses:

• Photosensitizer + light activation

Causes selective destruction of dysplastic cells.

Excellent for field disease.

PROGNOSIS

Most lesions remain stable or regress.

However:

• Some progress to invasive SCC.

Risk is higher in:

• Immunosuppressed patients

• Extensive field disease

• Hypertrophic lesions

EXAM-FOCUSED INSIGHTS

• Actinic keratosis is a premalignant keratinocytic lesion.

• Chronic UVB exposure is central.

• TP53 mutation is classic.

• Solar elastosis is hallmark evidence of photodamage.

• “Flag sign” is a favorite histology question.

• Rough texture is often easier to palpate than visualize.

• Partial-thickness atypia differentiates AK from Bowen disease.

• Field cancerization is a key conceptual point.

• Lower lip involvement = actinic cheilitis.

• Organ transplant recipients have markedly increased SCC risk.

MUST-KNOW BOARD EXAM QUESTIONS

1. What is actinic keratosis?

A premalignant UV-induced keratinocytic dysplasia.

2. Which ultraviolet wavelength is most important in pathogenesis?

UVB.

3. What is the most important tumor suppressor gene mutated in AK?

TP53.

4. What is solar elastosis?

Basophilic degeneration of dermal elastic tissue due to chronic UV exposure.

5. What is the “flag sign”?

Alternating parakeratosis and orthokeratosis over adnexal ostia.

6. What histologic feature differentiates AK from Bowen disease?

AK usually shows partial-thickness atypia; Bowen disease shows full-thickness atypia.

7. Which patients are at particularly high risk for progression to SCC?

Immunosuppressed patients, especially transplant recipients.

8. Why do actinic keratoses feel rough?

Due to hyperkeratosis and abnormal keratinization.

9. What is field cancerization?

Widespread subclinical UV-induced genetic alteration of skin surrounding visible lesions.

10. What is actinic cheilitis?

Premalignant actinic keratosis involving the lip vermilion.

11. Which topical drug inhibits thymidylate synthase in AK treatment?

Fluorouracil.

12. Which topical drug acts via TLR7 activation?

Imiquimod.

13. What histologic finding indicates progression to invasive SCC?

Dermal invasion by atypical squamous cells.

14. What is the hallmark dermal histologic feature of chronic photodamage?

Solar elastosis.

15. Why is p53 important in AK pathogenesis?

Loss of p53 function permits survival of UV-damaged keratinocytes.